Ongoing measles outbreaks across multiple states, fueled by low MMR vaccination coverage in susceptible communities, represent the main driver of rising U.S. case counts heading into late June 2026. As of June 4, the CDC reported 2,030 confirmed cases year-to-date—already approaching the full-year 2025 total of 2,288—with 93% outbreak-associated, 30 new outbreaks declared, and the vast majority occurring among unvaccinated or unknown-status individuals. Transmission remains highly efficient due to measles’ basic reproduction number of 12–18, with local spread far outpacing imported cases. Weekly CDC surveillance updates and state health department reports through June will provide the key data releases likely to influence near-term trader assessments of cumulative totals by month-end.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoMeasles cases in U.S. by June 30?
Measles cases in U.S. by June 30?
$32,395 Wol.
Jun 30, 2026
2150
40%
2200
10%
2300
6%
2400
2%
$32,395 Wol.
2150
$10,340 Wol.
40%
2200
$13,835 Wol.
10%
2300
$3,746 Wol.
6%
2400
$4,474 Wol.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles outbreaks across multiple states, fueled by low MMR vaccination coverage in susceptible communities, represent the main driver of rising U.S. case counts heading into late June 2026. As of June 4, the CDC reported 2,030 confirmed cases year-to-date—already approaching the full-year 2025 total of 2,288—with 93% outbreak-associated, 30 new outbreaks declared, and the vast majority occurring among unvaccinated or unknown-status individuals. Transmission remains highly efficient due to measles’ basic reproduction number of 12–18, with local spread far outpacing imported cases. Weekly CDC surveillance updates and state health department reports through June will provide the key data releases likely to influence near-term trader assessments of cumulative totals by month-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: May 28, 2026, 11:08 AM ET
Wolumen
$32,395Data zakończenia
Jun 30, 2026Rynek otwarty
May 28, 2026, 11:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles outbreaks across multiple states, fueled by low MMR vaccination coverage in susceptible communities, represent the main driver of rising U.S. case counts heading into late June 2026. As of June 4, the CDC reported 2,030 confirmed cases year-to-date—already approaching the full-year 2025 total of 2,288—with 93% outbreak-associated, 30 new outbreaks declared, and the vast majority occurring among unvaccinated or unknown-status individuals. Transmission remains highly efficient due to measles’ basic reproduction number of 12–18, with local spread far outpacing imported cases. Weekly CDC surveillance updates and state health department reports through June will provide the key data releases likely to influence near-term trader assessments of cumulative totals by month-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$32,395Data zakończenia
Jun 30, 2026Rynek otwarty
May 28, 2026, 11:08 AM ETResolver
0x65070BE91...Ongoing measles outbreaks across multiple states, fueled by low MMR vaccination coverage in susceptible communities, represent the main driver of rising U.S. case counts heading into late June 2026. As of June 4, the CDC reported 2,030 confirmed cases year-to-date—already approaching the full-year 2025 total of 2,288—with 93% outbreak-associated, 30 new outbreaks declared, and the vast majority occurring among unvaccinated or unknown-status individuals. Transmission remains highly efficient due to measles’ basic reproduction number of 12–18, with local spread far outpacing imported cases. Weekly CDC surveillance updates and state health department reports through June will provide the key data releases likely to influence near-term trader assessments of cumulative totals by month-end.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania